Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Esperion Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

11 Apr 2014 Reuters Investment Profile 12 $20.00

Value Graph: ESPERION THERAPE -- ESPR

11 Apr 2014 Ford Investor Services, Inc. 1 $12.00

Esperion Therapeutics, Inc. (ESPR) - Financial Analysis Review

Esperion Therapeutics, Inc. (ESPR) - Financial Analysis Review Summary Esperion Therapeutics, Inc. (Esperion) is a biotechnol...

18 Mar 2014 GlobalData 29 $125.00

ESPR.OQ - Event Transcript of Esperion Therapeutics Inc conference call, Mar. 05, 2014 / 4:30PM ET

Edited Event Transcript of ESPR.OQ conference call, Mar. 05, 2014 / 4:30PM ET Boston, Apr 10, 2014 (Thomson StreetEvent...

05 Mar 2014 Thomson Reuters StreetEvents 11 $75.00

Esperion Therapeutics, Inc. (ESPR) - Financial Analysis Review

Esperion Therapeutics, Inc. (ESPR) - Financial Analysis Review Summary Esperion Therapeutics, Inc. (Esperion) is a biotechnol...

10 Feb 2014 GlobalData 28 $125.00

ESPR - Esperion Therapeutics Inc - Downgraded to a Sell - Company Analysis and ASR Ranking Report

www.AlphaStreetResearch.com - Full Coverage of 3,000 U.S. equities. Reports include Financials, Ratios, Competitor Comparison...

27 Jan 2014 Alpha Street Research 9 $24.00

Esperion Therapeutics, Inc. (ESPR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Esperion Therapeutics, Inc. (ESPR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Esperion Therapeutics...

23 Jan 2014 GlobalData 22 $250.00

Esperion Therapeutics, Inc. (ESPR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Esperion Therapeutics, Inc. (ESPR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Esperion Therapeutics...

13 Dec 2013 GlobalData 21 $250.00

Esperion Therapeutics, Inc. (ESPR) - Financial Analysis Review

Esperion Therapeutics, Inc. (ESPR) - Financial Analysis Review Summary Esperion Therapeutics, Inc. (Esperion) is a biotechnol...

22 Nov 2013 GlobalData 28 $125.00

ESPERION THERAPEUTICS - STATIN ALTERNATIVE

Esperion’s recent NASDAQ IPO raised $75m net (5.75m shares at $14/s), providing the funds to advance its once-daily ETC-1002 ...

14 Aug 2013 Edison Investment Research 2 $10.00